Compare HCAI & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCAI | ADVB |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | China | United States |
| Employees | N/A | 31 |
| Industry | Miscellaneous manufacturing industries | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 6.2M |
| IPO Year | N/A | N/A |
| Metric | HCAI | ADVB |
|---|---|---|
| Price | $0.15 | $4.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 816.6K | 13.7K |
| Earning Date | 05-23-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $63.07 | ★ $1.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.19 |
| 52 Week High | $10.60 | $5.82 |
| Indicator | HCAI | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 37.31 | 58.50 |
| Support Level | $0.13 | $0.36 |
| Resistance Level | $0.20 | $5.71 |
| Average True Range (ATR) | 0.02 | 0.28 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 28.29 | 58.28 |
Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.